# ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

> **NCT01418092** · PHASE2 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 91 (actual)

## Conditions studied

- OIC

## Interventions

- **DRUG:** ALKS 37
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01418092
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01418092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01418092, "ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01418092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*